Icon ICLR
NASDAQ ICLR
$159.51 +1.17 (+0.74%)
As of: Sep 9, 2026 · 3:59 PM EDT

Icon (ICLR) Cost of Revenue (2009 - 2026)

Icon's (ICLR) quarterly Cost of Revenue came in at $1.6 billion in Q2 2026, up 8.82% year-over-year from $1.5 billion in Q2 2025, and up 1.81% quarter-over-quarter from $1.6 billion in Q1 2026.

Analysis

Icon (ICLR) Cost of Revenue (2009 - 2026) Analysis & Trends

Icon (ICLR) has reported Cost of Revenue for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Cost of Revenue rose 8.82% year-over-year to $1.6 billion in Q2 2026; TTM through Jun 2026 was $6.3 billion, a 8.45% increase from a year earlier, with the FY2025 full-year figure at $6.1 billion, up 4.44% from the prior year.
  • Cost of Revenue was $1.6 billion for Q2 2026 at Icon, up from $1.6 billion in the prior quarter.
  • Over five years, Cost of Revenue peaked at $1.6 billion in Q4 2025 and troughed at $1.4 billion in Q3 2022.
  • A 5-year average of $1.5 billion and a median of $1.4 billion in 2023 frame the typical range for Cost of Revenue.
  • Across the five-year window, Cost of Revenue soared 120.57% in 2022 and retreated 2.53% in 2025, its largest moves.
  • Over 5 years, Cost of Revenue stood at $1.4 billion in 2022, then climbed by 4.45% to $1.4 billion in 2023, then fell by 0.9% to $1.4 billion in 2024, then rose by 14.18% to $1.6 billion in 2025, then declined by 2.92% to $1.6 billion in 2026.
  • The last three Cost of Revenue figures came in at $1.6 billion (Q2 2026), $1.6 billion (Q1 2026), and $1.6 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cost of Rev (Qtr)
1 Iqvia Holdings 42.77 Bn 40.69 Bn 1.44 Bn 2.93 Bn
2 Medpace Holdings 16.50 Bn 16.00 Bn 201.64 Mn 505.69 Mn
3 Charles River Laboratories International 13.37 Bn 13.18 Bn 452.07 Mn 552.01 Mn
4 Icon 12.49 Bn 11.56 Bn 479.29 Mn 1.58 Bn
5 Fortrea Holdings 1.58 Bn 1.42 Bn 139.20 Mn 539.00 Mn
6 Evotec SE 642.83 Mn 216.96 Mn - -
7 Ginkgo Bioworks Holdings 422.55 Mn 338.02 Mn 18.44 Mn 1.72 Mn
8 Champions Oncology 69.16 Mn 69.16 Mn 7.03 Mn 6.81 Mn
9 MindWalk Holdings 59.83 Mn 51.55 Mn 1.82 Mn 1.18 Mn
10 VivoSim Labs 1.45 Mn 1.45 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.58 Bn
Mar 31, 2026 1.56 Bn
Dec 31, 2025 1.63 Bn
Sep 30, 2025 1.49 Bn
Jun 30, 2025 1.46 Bn
Mar 31, 2025 1.45 Bn
Dec 31, 2024 1.43 Bn
Sep 30, 2024 1.44 Bn
Jun 30, 2024 1.49 Bn
Mar 31, 2024 1.47 Bn
Dec 31, 2023 1.44 Bn
Sep 30, 2023 1.45 Bn
Jun 30, 2023 1.43 Bn
Mar 31, 2023 1.40 Bn
Dec 31, 2022 1.38 Bn
Sep 30, 2022 1.38 Bn
Jun 30, 2022 1.39 Bn
Mar 31, 2022 1.38 Bn
Dec 31, 2021 1.36 Bn
Sep 30, 2021 1.36 Bn